or Try an Advanced Search...

    Terlipressin Stocks List

    Symbol Grade Name % Change
    BIVI F BioVie Inc. -0.84
    View As Page of Charts
    Related Industries: Biotechnology
    Related Stock Lists: Clinical Medicine Digestive Diseases Drug Design FDA Hepatology Hepatorenal Syndrome Infusion Pump Liver Orphan Drug Refrigeration Sterility Syringe Treatment Of Hepatorenal Syndrome

    Related ETFs - A few ETFs which own one or more of the above listed Terlipressin stocks.

    Symbol Grade Name Weight
    VTWO C Vanguard Russell 2000 ETF 0.0
    HDG A ProShares Hedge Replication ETF 0.0
    IWC C iShares Microcap ETF 0.0
    IWO C iShares Russell 2000 Growth ETF 0.0
    URTY C ProShares UltraPro Russell2000 0.0
    View all Terlipressin ETFs...
    Compare ETFs
    Compare IWC to IWO Compare IWO to URTY Compare VTWO to HDG

        Terlipressin Stocks Recent News

        Date Stock Title
        Apr 25 BIVI BioVie Presents Data Showing Potential for Bezisterim (NE3107) to Reduce Inflammation and Restore Homeostasis in a Manner Correlated with Alzheimer’s Disease and Biomarker Endpoints
        Related Industries: Biotechnology
        Related Stock Lists: Clinical Medicine Digestive Diseases Drug Design FDA Hepatology Hepatorenal Syndrome Infusion Pump Liver Orphan Drug Refrigeration Sterility Syringe Treatment Of Hepatorenal Syndrome
        Terlipressin

        Terlipressin, sold under the brand name Terlivaz among others, is an analogue of vasopressin used as a vasoactive drug in the management of low blood pressure. It has been found to be effective when norepinephrine does not help. Terlipressin is a vasopressin receptor agonist.

        More about Terlipressin
        Browse All Tags